Epigenetic research is revolutionizing toxicology by providing new biomarkers for exposure and effect. These biomarkers can offer greater sensitivity and specificity than traditional methods, allowing for better risk assessment and management. Additionally, understanding the epigenetic basis of toxicity can lead to the development of targeted therapies and preventive strategies, enhancing public health protection.
